Dr Jimmie G Gavras, MD | |
188 Hospital Dr Ste 205, Fairhope, AL 36532-2038 | |
(251) 990-9191 | |
(251) 990-9189 |
Full Name | Dr Jimmie G Gavras |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 32 Years |
Location | 188 Hospital Dr Ste 205, Fairhope, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649255886 | NPI | - | NPPES |
92799 | Other | AL | BCBS OF ALABAMA PROVIDER |
000092799 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 17506 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Thomas Hospital | Fairhope, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Imc-cancer Surgery Of Mobile, Llc | 1557550589 | 16 |
News Archive
The immune system is comprised of multiple cell types each capable of specialized functions to protect the body from invading pathogens and promote tissue repair after injury. One cell type, known as monocytes, circulates throughout the organism in the blood and enters tissues to actively phagocytose (eat!) foreign cells and assist in tissue healing.
The Wall Street Journal examines upcoming changes to the global strategy to eradicate polio with a focus on the Bill & Melinda Gates Foundation's role in fighting the disease. "[O]rganizations behind the polio fight," which include the WHO, UNICEF, Rotary International and the CDC, "plan to announce a major revamp of their strategy to address shortcomings exposed by" the increasing number of polio outbreaks in "countries believed to have stopped the disease." The plan is expected to be announced next week.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.
Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA).
› Verified 3 days ago
Entity Name | Imc-cancer Surgery Of Mobile, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063714012 PECOS PAC ID: 1557550589 Enrollment ID: O20110106000691 |
News Archive
The immune system is comprised of multiple cell types each capable of specialized functions to protect the body from invading pathogens and promote tissue repair after injury. One cell type, known as monocytes, circulates throughout the organism in the blood and enters tissues to actively phagocytose (eat!) foreign cells and assist in tissue healing.
The Wall Street Journal examines upcoming changes to the global strategy to eradicate polio with a focus on the Bill & Melinda Gates Foundation's role in fighting the disease. "[O]rganizations behind the polio fight," which include the WHO, UNICEF, Rotary International and the CDC, "plan to announce a major revamp of their strategy to address shortcomings exposed by" the increasing number of polio outbreaks in "countries believed to have stopped the disease." The plan is expected to be announced next week.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.
Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jimmie G Gavras, MD 188 Hospital Dr Ste 205, Fairhope, AL 36532-2038 Ph: (251) 990-9191 | Dr Jimmie G Gavras, MD 188 Hospital Dr Ste 205, Fairhope, AL 36532-2038 Ph: (251) 990-9191 |
News Archive
The immune system is comprised of multiple cell types each capable of specialized functions to protect the body from invading pathogens and promote tissue repair after injury. One cell type, known as monocytes, circulates throughout the organism in the blood and enters tissues to actively phagocytose (eat!) foreign cells and assist in tissue healing.
The Wall Street Journal examines upcoming changes to the global strategy to eradicate polio with a focus on the Bill & Melinda Gates Foundation's role in fighting the disease. "[O]rganizations behind the polio fight," which include the WHO, UNICEF, Rotary International and the CDC, "plan to announce a major revamp of their strategy to address shortcomings exposed by" the increasing number of polio outbreaks in "countries believed to have stopped the disease." The plan is expected to be announced next week.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.
Researchers at Mount Sinai School of Medicine have found that even small amounts of damage to heart muscle during coronary artery bypass grafting (CABG) is associated with an increased risk of death, even among patients who initially do well following surgery. The study is published in the February 9 issue of the Journal of the American Medical Association (JAMA).
› Verified 3 days ago
James Richard Koehler, MD DDS Surgery Medicare: Not Enrolled in Medicare Practice Location: 7541 Cipriano Ct, Fairhope, Fairhope, AL 36532 Phone: 251-929-7850 Fax: 251-929-2500 | |
Stephen Roy Parden, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 119 High Pines Rdg, Fairhope, AL 36532 Phone: 251-751-1461 |